Open Beta
TREN
MetriLume
TREN

US marketsALKS

SEC-sourced researchBeta

ALKS

Alkermes plc.

Company comparison ↗

Data passport

CIK
0001520262
Exchange
Nasdaq
Business activity
Pharmaceutical Preparations · SIC 2834
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 1,663,405,000.0000 USD; December 2024: 1,557,632,000.0000 USD; December 2025: 1,475,899,000.0000 USD1.7B USD0 USD0December 2023December 2024December 2025
ALKS · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20231,663,405,000.0000Feb 25, 2026
December 20241,557,632,000.0000Feb 25, 2026
December 20251,475,899,000.0000Feb 25, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20251,475,899,000.0000241,664,000.0000520,754,000.00002,486,993,000.0000667,698,000.0000Feb 25, 2026
December 20241,557,632,000.0000367,070,000.0000439,124,000.00002,055,567,000.0000590,590,000.0000Feb 25, 2026
December 20231,663,405,000.0000355,757,000.0000401,353,000.0000——Feb 25, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

80/100
Profitability83
Growth45
Balance sheet73
Cash generation100
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$1.48BJan 1, 2025 – Dec 31, 2025Feb 25, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$1.56BJan 1, 2024 – Dec 31, 2024Feb 25, 202610-K
Net incomeNetIncomeLoss$241.66MJan 1, 2025 – Dec 31, 2025Feb 25, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$520.75MJan 1, 2025 – Dec 31, 2025Feb 25, 202610-K
Total assetsAssets$2.49BDec 31, 2025Feb 25, 202610-K
Total liabilitiesLiabilities$667.7MDec 31, 2025Feb 25, 202610-K

New filings

Explore methodology ↗